Nanomedicine News

RSS

Novel Nanotechnology Chips Help Perform Multidimensional and Multiplexed Immune-Monitoring Assays

A new study of genetically modified immune cells by scientists from UCLA and the California Institute of Technology could help improve a promising treatment for melanoma, an often fatal form of skin cancer.

From University of California, Los Angeles 25 Mar 2013

Nanomedicine Part of Major Age-Related Macular Degeneration Study

Northwestern University scientists are part of a multi-institution interdisciplinary consortium that has been awarded a $6.2 million grant over five years from the National Eye Institute to develop new treatments for exudative age-related macular degeneration (AMD).

25 Mar 2013

Nanotechnology-Inspired Technique Helps Detect Lyme Disease

Early diagnosis is critical in treating Lyme disease. However, nearly one quarter of Lyme disease patients are initially misdiagnosed because currently available serological tests have poor sensitivity and specificity during the early stages of infection. Misdiagnosed patients may go untreated and thus progress to late-stage Lyme disease, where they face longer and more invasive treatments, as well as persistent symptoms.

25 Mar 2013

Researchers Produce 2-D and 3-D Structures in the Field of DNA Nanotechnology

In a new discovery that represents a major step in solving a critical design challenge, Arizona State University Professor Hao Yan has led a research team to produce a wide variety of 2-D and 3-D structures that push the boundaries of the burgeoning field of DNA nanotechnology.

From Arizona State University 22 Mar 2013

Study Reveals Innermost Mechanisms of Nanomotors in Bacteria-Killing Virus

Scientists have cracked a 35-year-old mystery about the workings of the natural motors that are serving as models for development of a futuristic genre of synthetic nanomotors that pump therapeutic DNA, RNA or drugs into individual diseased cells.

From American Chemical Society 21 Mar 2013

Challenges in Nanotechnology Approach to Immunology Presented at TM World Conference

Nano Labs Corp. is pleased to report that Dr. Victor Castano, Chief Innovations Officer of Nano Labs, presented "A nanotechnology approach to immunology: challenges and opportunities." at the Target Meeting ("TM") 2nd World Immunology Online Conference.

21 Mar 2013

Fluorescent Material-Impregnated Nanoparticles Help Track Stem Cells Infused into the Heart

The promise of repairing damaged hearts through regenerative medicine — infusing stem cells into the heart in the hope that these cells will replace worn out or damaged tissue — has yet to meet with clinical success. But a highly sensitive visualization technique developed by Stanford University School of Medicine scientists may help speed that promise’s realization.

21 Mar 2013

CRF Honors UC Irvine Researcher for Designing Nano Drug Delivery System

Dr. Jennifer Simpson, a researcher at the University of California, Irvine, who is working on integrating current nanofabrication technologies with controlled drug delivery strategies in an effort to develop a new, sustained release treatment for corneal cystinosis, will be honored at the upcoming Natalie's Wish fundraiser for the Cystinosis Research Foundation.

20 Mar 2013

BCC’s Research Report on Nanotechnology

2012 continued to see major advances that were enabled by nanotechnology. In medicine in particular the delivery methods wrapped within nanoparticles have advanced many new and traditional drugs further along the clinical trial pipeline. Nano-engineering has also increased its grip on semiconductor manufacturing, and a multitude of quality control subsystems.

20 Mar 2013

New Biodegradable Nanoparticles Deliver Inflammation-Resolving Drugs to Sites of Tissue Injury

A multicenter team of researchers, including scientists at Columbia University Medical Center (CUMC), Brigham and Women's Hospital (BWH), Mount Sinai School of Medicine, and Massachusetts Institute of Technology, has developed biodegradable nanoparticles that are capable of delivering inflammation-resolving drugs to sites of tissue injury.

20 Mar 2013